Chapel Hill startup with ties to UNC lands rights to drug offering hope to cystic fibrosis patients
Posted Oct 27, 2019
Path BioAnalytics (PBA), a precision medicine startup with ties to UNC, has scored the rights to a new drug therapy offering hope to cystic fibrosis (CF) patients with rare mutations. PBA is a graduate of Launch Chapel Hill, an accelerator program based in Chapel Hill, as well as the Kenan Flagler Business School program Startup UNC.
(WRAL Tech Wire)
Related: Campus Connections
Hannah Storm, Rich Eisen discuss impact Stuart Scott would have had todayCelebrated ESPN anchor Stuart Scott would have been 60 years old this year, and his former colleagues continue to mourn not only losing a friend...
Tue Mar 11, 2025Mack Brown Lists Nine-Bathroom Chapel Hill Home For Sale After Move to Austin
Former UNC football coach Mack Brown has listed his five-bedroom, nine-bathroom home in Chapel Hill for sale. The 9,913 square-foot mansion on Tenney Circle features...
Sat Mar 8, 2025
Fans, Franklin Street businesses excited as UNC, Duke face off to end regular season
Chapel Hill Sportswear is gearing up for crowds of its own this weekend. “It’s definitely been busier than a normal Friday, any other Friday,” said...
Sat Mar 8, 2025
Tailgate, Shrunken Head Boutique's expansion store, holds grand opening
On Feb. 28, Tailgate by Shrunken Head Boutique, located three doors down, hosted its grand opening. Tailgate is the extension of Shrunken Head Boutique, which...
Thu Mar 6, 2025